Search

  6. ProQR to Present at Two Upcoming Investor Conferences in March

    Press release

    LEIDEN, the Netherlands, March 01, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases including cystic fibrosis (CF), Leber's congenital

  7. ProQR Announces Financial Results for the Second Quarter of 2019

    Press release

    … ProQR Announces Financial Results for the Second Quarter of … Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … progress towards accomplishing the goals set out in ProQR’s Vision 2023 strategy, which includes starting the …

  9. ProQR to Present at the RBC Capital Markets Healthcare Conference

    Press release

    LEIDEN, the Netherlands and CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced